10.1210/jc.2004-2190
In patients with Hashimoto's, understanding these genetic factors can support a more nuanced conversation with your provider about whether GLP-1 therapy aligns with your individual metabolic profile and immune stability
Weight loss programs must include exercise, including medical weight loss
Possible role of butyrylcholinesterase in fat loss and decreases in inflammatory levels in patients with multiple sclerosis after treatment with epigallocatechin gallate and coconut oil: A pilot study
Leggio says the good news is that there are now several such clinical trials underway, including one he is overseeing at NIH, that look at how these medications affect peoples drinking and substance use habits.
Genazzani AD, Santagni S, Rattighieri E, Chierchia E, Despini G, Marini G, et al